API2-MALT1 chimeric transcript-positive gastroduodenal MALT lymphoma with subsequent development of adenocarcinoma as a collision tumour over a clinical course of 7 years.
Isaka
T
T
Nakamura
T
T
Tajika
M
M
Kawai
H
H
Imaoka
H
H
Okamoto
Y
Y
Aoki
M
M
Inoue
H
H
Takahashi
K
K
Mizuno
N
N
Sawaki
A
A
Yamao
K
K
Seto
M
M
Yokoi
T
T
Yatabe
Y
Y
Nakamura
S
S
D000230:Adenocarcinoma / Q000175:diagnosis / Q000473:pathology*; D002471:Cell Transformation, Neoplastic; D002678:Chimera / Q000235:genetics; D018450:Disease Progression; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000378:metabolism* / Q000473:pathology; D006801:Humans; D018442:Lymphoma, B-Cell, Marginal Zone / Q000378:metabolism* / Q000473:pathology; D008875:Middle Aged; D015514:Oncogene Proteins, Fusion / Q000235:genetics / Q000378:metabolism*; D013274:Stomach Neoplasms / Q000175:diagnosis / Q000473:pathology*; D013997:Time Factors
C415943:API2-MALT1 fusion protein, human; D015514:Oncogene Proteins, Fusion